Aldeyra Therapeutics Inc. buy BiotechBee
Start price
01.10.23
/
70%
€6.42
Target price
30.11.25
€10.00
Performance (%)
-73.55%
End price
16.10.23
€1.70
Summary
This prediction ended on 16.10.23 with a price of €1.70. The BUY prediction by BiotechBee for Aldeyra Therapeutics Inc. performed very badly with a performance of -73.55%. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Aldeyra Therapeutics Inc. | -14.191% | -14.191% | -29.821% |
| iShares Core DAX® | -5.868% | -2.496% | 2.292% |
| iShares Nasdaq 100 | 1.660% | 3.513% | 13.191% |
| iShares Nikkei 225® | -6.126% | 2.136% | 27.665% |
| iShares S&P 500 | 0.504% | 2.045% | 9.817% |
According to BiotechBee what are the pros and cons of Aldeyra Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Aldeyra Therapeutics Inc. diskutieren
Buy mit Kursziel 10,0